Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643057 · ClinicalTrials.gov registry record
Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health
A clinical trial, sponsored by Wyss Institute at Harvard University.
- Completed
- Registry status
- 36
- Enrollment target
NCT01643057: Completed study, sponsored by Wyss Institute at Harvard University.
NCT01643057 is a clinical trial that has completed, run by Wyss Institute at Harvard University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01643057 has completed, sponsored by Wyss Institute at Harvard University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to explore physiological interventions and biomarkers for Apnea of Prematurity in newborn infants.
Primary Outcome
Focus on inter-breath intervals and oxygen desaturation.
Interventions
- DEVICE Stochastic Resonance Mattress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-07 |
What the finished NCT01643057 record still lists
NCT01643057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Stochastic Resonance Mattress is the first listed.
NCT01643057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01643057 about?
NCT01643057 is a clinical study titled "Stochastic Resonance Mattress (Physiological Interventions) and Biomarkers for Enhancing Neonatal Health". The purpose of this study is to explore physiological interventions and biomarkers for Apnea of Prematurity in newborn infants.
What is the current status of trial NCT01643057?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2012-07. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01643057?
The interventions under investigation include: Stochastic Resonance Mattress (DEVICE).
Who is sponsoring clinical trial NCT01643057?
This trial is sponsored by Wyss Institute at Harvard University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT01627301 · started 2012-07 · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT01638676 · started 2012-07 · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01639508 · started 2012-07 · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT01696721 · started 2012-07
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy